Form D · Biotechnology
Dimension Therapeutics, Inc.
Cambridge, MA · CIK 0001592288
Offering snapshot reported Apr 23, 2015 · SEC filing
- Reported sold
- $65M Offering amount: $65M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 20, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 23, 2015 | Initial | $64,999,986 | No comparison | 12 | SEC filing |
| Feb 11, 2015 | Amendment | $24,500,000 | $19,500,000vs Nov 18, 2013 | 2 | SEC filing |
| Nov 18, 2013 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-238522
Source: Form D, filed Apr 23, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Benjamin Auspitz | Director |
| Thomas Beck | Director, Executive |
| Allan Fox | Director |
| Rishi Gupta | Director |
| Jay K. Hachigian | Executive |
| Donald J. Hayden | Director |
| Donald J. Hayden, Jr. | Director |
| Annalisa Jenkins | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
840 Memorial Drive, 4th Floor
Cambridge, MA, 02139
Cambridge, MA, 02139